Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
Clinical trial NCT00241111 · COMPLETED
Trial details
- NCT number
- NCT00241111
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2006-01-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.